| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years (NCT02082639) | GlaxoSmithKline | 2015-02-01 |
| Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study (NCT02100618) | GlaxoSmithKline | 2015-01-01 |
| Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom (NCT01953822) | GlaxoSmithKline | 2013-10-01 |
| Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UK (NCT01905462) | GlaxoSmithKline | 2012-11-01 |
| Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old (NCT01627561) | GlaxoSmithKline | 2012-10-15 |
| Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study (NCT01418937) | GlaxoSmithKline | 2012-05-29 |
| Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females (NCT01462357) | GlaxoSmithKline | 2011-11-21 |
| Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada (NCT01290393) | GlaxoSmithKline | 2011-09-26 |
| Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects (NCT01190176) | GlaxoSmithKline | 2011-09-12 |
| Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls (NCT01381575) | GlaxoSmithKline | 2011-06-29 |
| Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study (NCT01190189) | GlaxoSmithKline | 2011-04-01 |
| Study to Assess Immune Responses and Safety of the GSK-580299 Vaccine in Healthy Women (26 to 45 Years) (NCT01277042) | GlaxoSmithKline | 2011-02-17 |
| The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study (NCT01249365) | GlaxoSmithKline | 2011-01-24 |
| Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females (NCT01031069) | GlaxoSmithKline | 2010-10-26 |
| Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination (NCT01153906) | GlaxoSmithKline | 2010-10-01 |
| Drug Use Investigation for Cervarix® (NCT01187927) | GlaxoSmithKline | 2010-09-01 |
| Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females (NCT01101542) | GlaxoSmithKline | 2010-07-01 |
| Study of Natural History of Human Papillomavirus (HPV) Infections in Adult Women With Recurrent Conizations in Norway (NCT00924794) | GlaxoSmithKline | 2010-06-01 |
| Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia (NCT01213459) | GlaxoSmithKline | 2010-04-01 |
| Immunogenicity and Safety Study of GSK Biologicals' Human Papillomavirus 580299 Vaccine in Healthy Female Subjects (NCT00996125) | GlaxoSmithKline | 2009-10-24 |
| Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects (NCT00947115) | GlaxoSmithKline | 2009-09-22 |
| Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects (NCT00937950) | GlaxoSmithKline | 2009-08-05 |
| Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study (NCT00929526) | GlaxoSmithKline | 2009-06-01 |
| Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects. (NCT00877877) | GlaxoSmithKline | 2009-05-07 |
| Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects. (NCT00811798) | GlaxoSmithKline | 2009-05-01 |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand (NCT00849381) | GlaxoSmithKline | 2009-04-01 |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US (NCT00799825) | GlaxoSmithKline | 2009-01-01 |
| Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects (NCT00779766) | GlaxoSmithKline | 2008-10-22 |
| Cervarix Long-term Safety Surveillance (NCT01498627) | GlaxoSmithKline | 2008-08-01 |
| Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects (NCT00652938) | GlaxoSmithKline | 2008-04-09 |
| Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299) (NCT00637195) | GlaxoSmithKline | 2008-03-11 |
| Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females (NCT00586339) | GlaxoSmithKline | 2008-01-17 |
| Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America (NCT00546078) | GlaxoSmithKline | 2008-01-14 |
| Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects (NCT00578227) | GlaxoSmithKline | 2007-12-15 |
| A Single Centre Study to Evaluate the Safety and Immunogenicity of the Human Papillomavirus Vaccine (GSK-580299) in Chinese Females (NCT00549900) | GlaxoSmithKline | 2007-12-02 |
| Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age (NCT00552279) | GlaxoSmithKline | 2007-11-12 |
| Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil (NCT00518336) | GlaxoSmithKline | 2007-11-01 |
| Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs (NCT00541970) | GlaxoSmithKline | 2007-10-17 |
| Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents (NCT00534638) | GlaxoSmithKline | 2007-10-04 |
| Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer (NCT01207999) | GlaxoSmithKline | 2007-10-01 |
| Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age (NCT00492544) | GlaxoSmithKline | 2007-07-02 |
| A Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine/Cervarix TM Vaccine in Healthy Females Aged 15-25 Years (NCT00485732) | GlaxoSmithKline | 2007-06-11 |
| Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A) (NCT00478621) | GlaxoSmithKline | 2007-05-25 |
| Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years (NCT00456807) | GlaxoSmithKline | 2007-04-01 |
| Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects (NCT00426361) | GlaxoSmithKline | 2007-02-13 |
| Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age (NCT00423046) | GlaxoSmithKline | 2007-01-24 |
| Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects (NCT00369824) | GlaxoSmithKline | 2006-09-26 |
| Study to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years (NCT00345878) | GlaxoSmithKline | 2006-09-25 |
| Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine (NCT00359619) | GlaxoSmithKline | 2006-09-12 |
| Evaluation of the Immune and Safety Response of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine in Healthy Indian Women (NCT00344032) | GlaxoSmithKline | 2006-07-28 |
| Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine (NCT00316693) | GlaxoSmithKline | 2006-04-26 |
| Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males. (NCT00309166) | GlaxoSmithKline | 2006-04-05 |
| A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years (NCT00306241) | GlaxoSmithKline | 2006-03-01 |
| Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older (NCT00294047) | GlaxoSmithKline | 2006-02-16 |
| Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years (NCT00290277) | GlaxoSmithKline | 2005-11-01 |
| Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation. (NCT00250276) | GlaxoSmithKline | 2005-10-28 |
| Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine. (NCT00231413) | GlaxoSmithKline | 2005-03-04 |
| Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18 (NCT00196937) | GlaxoSmithKline | 2004-10-07 |
| Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18 (NCT00169494) | GlaxoSmithKline | 2004-09-01 |
| Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18. (NCT00196924) | GlaxoSmithKline | 2004-06-01 |
| Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 (NCT00122681) | GlaxoSmithKline | 2004-05-06 |
| Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults (NCT00120848) | GlaxoSmithKline | 2003-11-01 |
| Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women (NCT00689741) | GlaxoSmithKline | 2001-01-01 |
| Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females (NCT00693615) | GlaxoSmithKline | 2000-10-01 |